Results
Precirix and IFE sign clinical trial manufacturing agreement
VUB spin-off Precirix , a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and the Institute for Energy Technology (IFE), a manufacturer of radiopharmaceutical products based in Norway, announced an agreement for the supply of Precirix’ radiopharmace...
Read more
Follow us on LinkedIn
VUB TechTransfer has its own LinkedIn business page! Are you also on LinkedIn? Follow us for updates on VUB's innovative research, news from our spin-offs and collaboration opportunities. Follow us
Read more
COMBAT-project fights animal parasitic disease
CIRAD, as coordinator of a consortium of 21 partners of which the VUB, has launched a new project to combat animal trypanosomosis, a parasitic disease transmitted by biting flies, including the infamous tsetse. VUB researcher Stefan Magez of the Department of Bio-engineering Sciences Cellu...
Read more
New capital round values Collibra at $5 billion
VUB spin-off Collibra has raised $250M in a funding round led by Sequoia Capital. This makes Collibra the most valuable Belgian tech company. Collibra is an enterprising software company and a spin-off from the Laboratory for Semantic Technology and Applications Resea...
Read more
ERIS survey for researchers
Within TechTransfer, the ERIS team is responsible for assisting VUB's research community in their quest for European funding for applied research.
Read more
PharmaFluidics acquired by Thermo Fisher Scientific
PharmaFluidics is now part of Thermo Fisher Scientific, the world leader in serving science. This acquisition brings about new opportunities to create greater value and strengthens its ability to fulfill Thermo Fisher’s mission, which is to enable customers to make the...
Read more
SOPHIA: deploying robots for improved ergonomy
VUB research by research group Human Physiology and Sports Physiotherapy (MFYS) shows that more than half of European workers have long-term muscle and bone complaints. Innovative robots, cobots and exoskeletons that can relieve that work and make it healthier are therefore a ma...
Read more
VUB Green Energy Park and Photonics in De Standaard Innovation Special
Read the articles about the large-scale living lab Green Energy Park and the one-stop-shop for photonics in De Standaard. We teamed up with Maarten Messagie and Thierry Coosemans of the VUB research group Evergi and Nathalie Debaes of B-PHOT.
Read more
VUB and EsoBiotec ready to transform cell therapy cancer treatments
EsoBiotec, a recently founded biotech company, announces a EUR 6 million pre-series A round comprised of non-dilutive funding from the Walloon Government combined with seed investments from venture capitalist Thuja Capital and regional funding agencies SRIW Life Sciences and Sambrinvest.
Read more
Downloads
Read more